These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 21590771

  • 1. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas.
    Wiegand KC, Lee AF, Al-Agha OM, Chow C, Kalloger SE, Scott DW, Steidl C, Wiseman SM, Gascoyne RD, Gilks B, Huntsman DG.
    J Pathol; 2011 Jul; 224(3):328-33. PubMed ID: 21590771
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ARID1A mutations in endometriosis-associated ovarian carcinomas.
    Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih IeM, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA, Huntsman DG.
    N Engl J Med; 2010 Oct 14; 363(16):1532-43. PubMed ID: 20942669
    [Abstract] [Full Text] [Related]

  • 7. A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.
    Wiegand KC, Hennessy BT, Leung S, Wang Y, Ju Z, McGahren M, Kalloger SE, Finlayson S, Stemke-Hale K, Lu Y, Zhang F, Anglesio MS, Gilks B, Mills GB, Huntsman DG, Carey MS.
    BMC Cancer; 2014 Feb 22; 14():120. PubMed ID: 24559118
    [Abstract] [Full Text] [Related]

  • 8. Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers.
    Lowery WJ, Schildkraut JM, Akushevich L, Bentley R, Marks JR, Huntsman D, Berchuck A.
    Int J Gynecol Cancer; 2012 Jan 22; 22(1):9-14. PubMed ID: 22193641
    [Abstract] [Full Text] [Related]

  • 9. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC, Mariappan MR, Putcha GV, Husain A, Chun N, Ford JM, Schrijver I, Longacre TA.
    Am J Surg Pathol; 2008 Jul 22; 32(7):1029-37. PubMed ID: 18469706
    [Abstract] [Full Text] [Related]

  • 10. BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer.
    Stamp JP, Gilks CB, Wesseling M, Eshragh S, Ceballos K, Anglesio MS, Kwon JS, Tone A, Huntsman DG, Carey MS.
    Int J Gynecol Cancer; 2016 Jun 22; 26(5):825-32. PubMed ID: 27051059
    [Abstract] [Full Text] [Related]

  • 11. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW, Ellenson LH, Soslow RA.
    Mod Pathol; 2002 Oct 22; 15(10):1032-7. PubMed ID: 12379748
    [Abstract] [Full Text] [Related]

  • 12. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
    McConechy MK, Anglesio MS, Kalloger SE, Yang W, Senz J, Chow C, Heravi-Moussavi A, Morin GB, Mes-Masson AM, Australian Ovarian Cancer Study Group, Carey MS, McAlpine JN, Kwon JS, Prentice LM, Boyd N, Shah SP, Gilks CB, Huntsman DG.
    J Pathol; 2011 Apr 22; 223(5):567-73. PubMed ID: 21381030
    [Abstract] [Full Text] [Related]

  • 13. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.
    Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, Shih IeM.
    Int J Gynecol Pathol; 2012 Jul 22; 31(4):297-303. PubMed ID: 22653341
    [Abstract] [Full Text] [Related]

  • 14. Precursors of endometrial clear cell carcinoma.
    Fadare O, Liang SX, Ulukus EC, Chambers SK, Zheng W.
    Am J Surg Pathol; 2006 Dec 22; 30(12):1519-30. PubMed ID: 17122507
    [Abstract] [Full Text] [Related]

  • 15. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
    Zorn KK, Bonome T, Gangi L, Chandramouli GV, Awtrey CS, Gardner GJ, Barrett JC, Boyd J, Birrer MJ.
    Clin Cancer Res; 2005 Sep 15; 11(18):6422-30. PubMed ID: 16166416
    [Abstract] [Full Text] [Related]

  • 16. [Molecular carcinogenesis of ovarian carcinoma].
    Diebold J.
    Verh Dtsch Ges Pathol; 2005 Sep 15; 89():77-83. PubMed ID: 18035676
    [Abstract] [Full Text] [Related]

  • 17. bcl-2 expression in endometrial hyperplasia and carcinoma.
    Niemann TH, Trgovac TL, McGaughy VR, Vaccarello L.
    Gynecol Oncol; 1996 Dec 15; 63(3):318-22. PubMed ID: 8946865
    [Abstract] [Full Text] [Related]

  • 18. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
    Bartosch C, Manuel Lopes J, Oliva E.
    Adv Anat Pathol; 2011 Nov 15; 18(6):415-37. PubMed ID: 21993268
    [Abstract] [Full Text] [Related]

  • 19. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
    Heckl M, Schmoeckel E, Hertlein L, Rottmann M, Jeschke U, Mayr D.
    PLoS One; 2018 Nov 15; 13(2):e0192881. PubMed ID: 29451900
    [Abstract] [Full Text] [Related]

  • 20. Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium.
    Lax SF.
    Pathology; 2007 Feb 15; 39(1):46-54. PubMed ID: 17365822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.